Bond Solventis 5.4% ( US83444MAP68 ) in USD
| Issuer | Solventis |
| Market price | |
| Country | United States
|
| ISIN code |
US83444MAP68 ( in USD )
|
| Interest rate | 5.4% per year ( payment 2 times a year) |
| Maturity | 01/03/2029 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 498 776 000 USD |
| Cusip | 83444MAP6 |
| Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) |
| Moody's rating | Baa3 ( Lower medium grade - Investment-grade ) |
| Next Coupon | 01/09/2026 ( In 178 days ) |
| Detailed description |
Solventum is a proprietary blend of solvents used in various industrial and laboratory applications, often for cleaning, extraction, or dissolving materials. An analysis of the current fixed-income landscape highlights a notable bond offering from Solventum, a key player in the healthcare sector. Solventum, recently established as an independent global healthcare company following its spin-off from 3M, focuses on delivering innovative solutions in areas such as wound care, oral care, and surgical solutions. This specific debt instrument, originating from the United States market, carries the ISIN US83444MAP68 and CUSIP 83444MAP6. As of recent market observations, the bond is trading at 102.373% of its par value and is denominated in U.S. Dollars (USD). It features a fixed annual interest rate of 5.4%, with coupon payments structured to occur semi-annually. The total size of this particular bond issuance amounts to USD 1,498,776,000, and it is accessible to investors with a minimum purchase increment of USD 2,000. The bond has a defined maturity date of March 1, 2029, providing a clear timeframe for capital return. Its creditworthiness is evaluated by leading rating agencies, securing a BBB- rating from Standard & Poor's and a Baa3 rating from Moody's, reflecting their assessment of the issuer's capacity to meet its financial obligations. |
Français
Italiano
United States